175 (1): 21720, discussion 2201
October 4, 2024: Large Number of Plaintiffs File Ozempic Lawsuits in September As of October 1, 2024, there were 1,090 cases pending in MDL 3092, Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
Clients in Katy and The Woodlands often explore this option when rest, stretching, physical therapy, or anti-inflammatories arent moving the needle
But I havent seen a viable turnaround path: If Hims can legally compound personalized doses dose flexibility wont solve nausea, muscle-loss, or tapering needs (source)
The gap between your current weight and your pre-pregnancy weight starts closing in a way that feels real rather than aspirational